Infectious diseases now最新文献

{"title":"Impact of Open Access status on journal metrics in infectious diseases and clinical microbiology – A cross-sectional study","authors":"Noam Tau ,&nbsp;Marin Moutel ,&nbsp;Maiwenn Petithomme-Nanrocki ,&nbsp;Maxime Hentzien ,&nbsp;Dafna Yahav","doi":"10.1016/j.idnow.2024.104909","DOIUrl":"https://doi.org/10.1016/j.idnow.2024.104909","url":null,"abstract":"<div><h3>Introduction</h3><p>While Open Access (OA) journals provide free access to articles, they entail high article processing charges (APC), limiting opportunities for young researchers and those from low-middle income countries to publish OA.</p></div><div><h3>Methods</h3><p>Cross-sectional study, evaluating APC and academic impact of full OA (FOA) journals in infectious diseases (ID) and clinical microbiology (CM) compared to hybrid journals. Data were collected from Journal Citation Reports and journals’ websites.</p></div><div><h3>Results</h3><p>Among 255 journals, median APC was 2850 (interquartile range [IQR] 1325–3654$). Median APC for 120 FOA journals was significantly lower than for 119 hybrid journals (2000, IQR 648–2767$ versus 3550, IQR 2948–4120$, p &lt; 0.001). FOA journals had lower citation numbers and impact metrics compared to hybrid journals.</p></div><div><h3>Conclusion</h3><p>While FOA ID/CM journals have lower APCs, they also lower academic impact compared to hybrid journals. These findings highlight the need for reforms in the publication process in view of achieving equitable data dissemination.</p></div>","PeriodicalId":13539,"journal":{"name":"Infectious diseases now","volume":"54 4","pages":"Article 104909"},"PeriodicalIF":3.5,"publicationDate":"2024-04-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666991924000642/pdfft?md5=547c21cbce0d039bd70bb4525b89de05&pid=1-s2.0-S2666991924000642-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140555452","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Providing parents with HPV vaccine information from a male perspective may render them more inclined to have their daughters vaccinated","authors":"Sandra Chyderiotis ,&nbsp;Sarah Derhy ,&nbsp;Julie Gaillot ,&nbsp;Alexandre Cobigo ,&nbsp;Laura Zanetti ,&nbsp;Clément Piel ,&nbsp;Judith E. Mueller","doi":"10.1016/j.idnow.2024.104908","DOIUrl":"https://doi.org/10.1016/j.idnow.2024.104908","url":null,"abstract":"<div><h3>Objectives</h3><p>Several high-income countries have implemented a gender-neutral vaccination program against human papillomavirus (HPV) infections. The impact of a gender-neutral program (GNP) on parental intention to vaccinate their daughters has not been studied, especially in countries with low HPV vaccine coverage among girls.</p></div><div><h3>Patients and methods</h3><p>In July 2019, before a GNP was implemented in France (2021), the French National Cancer Institute (INCa) conducted a survey on HPV vaccine acceptance among parents of children aged 11–19 years living in France. In the sample of girls’ parents (n = 1424 parents, 1726 girls), we investigated whether parents who declared no initial intention to have their daughter(s) vaccinated changed their minds after reading information including a male perspective on HPV consisting in description of HPV-related disease among men and in ascertainment of the fact that in some countries, the HPV vaccine is recommended for boys, after which they were once again asked about their intentions “if the vaccine were recommended to boys and girls alike”.</p></div><div><h3>Results</h3><p>As regards 295 (25.7 %) of the 1147 unvaccinated girls, their parents declared no intention to have them vaccinated, while 509 (44.4 %) were not sure. Among the parents of the 804 girls whose parents had not intended to have them vaccinated, 134 (16.7 %) changed their minds after reading about HPV among men. Fathers were more likely than mothers to change their minds, and finally intend to have their daughters vaccinated (adjusted relative risk, 1.74 [95 % confidence interval, 1.20,2.54]).</p></div><div><h3>Conclusions</h3><p>These results suggest that parents, and fathers in particular, could be more motivated to have their daughters vaccinated against HPV if the information with which they were provided included a male perspective and a recommendation of vaccination for boys as well as girls.</p></div>","PeriodicalId":13539,"journal":{"name":"Infectious diseases now","volume":"54 4","pages":"Article 104908"},"PeriodicalIF":3.5,"publicationDate":"2024-04-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666991924000630/pdfft?md5=f2035ff43fdcd9f289e6a85c4d547b4f&pid=1-s2.0-S2666991924000630-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140558935","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"ChatGPT ability and urinary tract infection-related questions: Comment","authors":"Hinpetch Daungsupawong ,&nbsp;Viroj Wiwanitkit","doi":"10.1016/j.idnow.2024.104907","DOIUrl":"https://doi.org/10.1016/j.idnow.2024.104907","url":null,"abstract":"","PeriodicalId":13539,"journal":{"name":"Infectious diseases now","volume":"54 4","pages":"Article 104907"},"PeriodicalIF":3.5,"publicationDate":"2024-04-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666991924000629/pdfft?md5=206ad51ef669ed5257e7d69a10298b2e&pid=1-s2.0-S2666991924000629-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140533583","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Assessment of the impact of telehealth intervention in patients with bone and joint infection","authors":"Philippine Marque ,&nbsp;Julie Leitao ,&nbsp;Fréderic-Antoine Dauchy ,&nbsp;Olivier Gerbouin ,&nbsp;Thierry Fabre ,&nbsp;Fabien Xuereb ,&nbsp;Marin Lahouati","doi":"10.1016/j.idnow.2024.104906","DOIUrl":"https://doi.org/10.1016/j.idnow.2024.104906","url":null,"abstract":"<div><h3>Objectives</h3><p>Patients with bone and joint infections (BJI) are involved in a complex care pathway and require prolonged antimicrobial treatment. Some studies have suggested that a pharmacist-led telehealth intervention (TI) could help to ensure better follow-up of chronic diseases. To our knowledge, there are no data on the effects of pharmacist-led TI on patients with BJI. The aim of this study is to assess the impact of a TI on patients treated for BJIs at three weeks after hospital discharge.</p></div><div><h3>Patients and Methods</h3><p>Patients encountered during hospitalization and receiving standardized care including TI were included in the study. All adverse events (AE) reported by patients during TI were evaluated. Impact of pharmaceutical interventions (PIs) provided by a clinical pharmacist following TI was evaluated by CLEO© (CLinical, Economic and Organizational) scale. Patient satisfaction concerning TI was assessed by an anonymous questionnaire following medical consultation at the end of antimicrobial treatment.</p></div><div><h3>Results</h3><p>Over a 4-month period, 36 patients received TI. Fifty-two AEs were identified in 21 patients (58%). Two patients were hospitalized due to an AE. Clinical pharmacists provided 34 pharmaceutical interventions (PIs) for 23 patients (64%). According to CLEO scale, 11 PIs had a major clinical impact (32%), 6 PIs (18%) had a favorable impact on the direct cost of treatment and 27 PIs (79%) had positive organizational impact. Concerning TI process, patients were satisfied or very satisfied, with an average score of 9.6/10.</p></div><div><h3>Conclusion</h3><p>TI led to a high number of pharmaceutical interventions (PIs), with a meaningful clinical, organizational, and economic impact. Patients were also highly satisfied with this intervention.</p></div>","PeriodicalId":13539,"journal":{"name":"Infectious diseases now","volume":"54 4","pages":"Article 104906"},"PeriodicalIF":3.5,"publicationDate":"2024-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666991924000617/pdfft?md5=8bb52774d90244caa5488f212079ba91&pid=1-s2.0-S2666991924000617-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140533582","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"From imprecise “immune debt” to nuanced “immune shortage”?","authors":"Luwen Zhang","doi":"10.1016/j.idnow.2024.104894","DOIUrl":"10.1016/j.idnow.2024.104894","url":null,"abstract":"","PeriodicalId":13539,"journal":{"name":"Infectious diseases now","volume":"54 5","pages":"Article 104894"},"PeriodicalIF":3.5,"publicationDate":"2024-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666991924000496/pdfft?md5=5abcdab9741932d83bdd80614f3b950d&pid=1-s2.0-S2666991924000496-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140318207","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Immune debt or immune shortage: The controversy continues – “Season 3 episode 1”","authors":"Robert Cohen,&nbsp;Corinne Levy","doi":"10.1016/j.idnow.2024.104897","DOIUrl":"10.1016/j.idnow.2024.104897","url":null,"abstract":"","PeriodicalId":13539,"journal":{"name":"Infectious diseases now","volume":"54 5","pages":"Article 104897"},"PeriodicalIF":3.5,"publicationDate":"2024-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666991924000526/pdfft?md5=00857bd86d2d975b9a30abbb383e9d29&pid=1-s2.0-S2666991924000526-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140326553","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Bronchiolitis 2022–2023: One of the most unexpected outbreaks over this past decade, Nouvelle-Aquitaine, France","authors":"Gaëlle Gault ,&nbsp;Laure Meurice ,&nbsp;Anais Lamy ,&nbsp;Caroline Couturier ,&nbsp;Pascal Vilain ,&nbsp;Céline Etchetto ,&nbsp;Laurent Filleul","doi":"10.1016/j.idnow.2024.104896","DOIUrl":"10.1016/j.idnow.2024.104896","url":null,"abstract":"<div><h3>Background</h3><p>Since the Covid-19 pandemic, bronchiolitis outbreaks have been subject to disrupted seasonality, and a major impact on the healthcare system was observed in 2022–23.</p></div><div><h3>Objective</h3><p>The aim of this article is to describe the characteristics of the 2022–23 bronchiolitis epidemic in the Nouvelle-Aquitaine region, and its impact on the healthcare system.</p></div><div><h3>Method</h3><p>We described the indicators of dynamics, intensity, severity and impact provided by the bronchiolitis monitoring in place, and compared these with those from previous seasons.</p></div><div><h3>Results</h3><p>The intensity of the 2022–23 epidemic (emergency department visits: 23 %; SOS Médecins acts: 15 %), and its impact in terms of bronchiolitis-related hospitalizations (45 %) were higher than in previous seasons (p &lt; 0.05).</p></div><div><h3>Conclusion</h3><p>In addition to earliness, the 2022–23 bronchiolitis epidemic was significant as regards its exceptional scale and major impact on the hospital system, requiring adaptation of the preexisting healthcare offer in response to the anticipated demand.</p></div>","PeriodicalId":13539,"journal":{"name":"Infectious diseases now","volume":"54 4","pages":"Article 104896"},"PeriodicalIF":3.5,"publicationDate":"2024-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666991924000514/pdfft?md5=5f1c60496214225fc1d939205d7d5a5c&pid=1-s2.0-S2666991924000514-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140318205","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Prevalence of antimicrobial use and healthcare-associated infections in the UAE: Results from the first nationwide point-prevalence survey","authors":"Najiba Abdulrazzaq,&nbsp;Ayman Chkhis","doi":"10.1016/j.idnow.2024.104891","DOIUrl":"10.1016/j.idnow.2024.104891","url":null,"abstract":"<div><h3>Objectives</h3><p>The WHO’s Global Antimicrobial Resistance Surveillance System (GLASS) 2017–2018 reported a significant increase in antimicrobial resistance among nosocomial pathogens. This was the first national point of prevalence survey in United Arab Emirates.</p></div><div><h3>Methods</h3><p>A one-day multicenter cross-sectional survey using a unified web-based platform was conducted in forty-four hospitals across the country from 3 to 23 November 2019 to estimate the prevalence of antimicrobial use and healthcare-associated infections among both governmental and private sectors.</p></div><div><h3>Results</h3><p>All in all, 3657 inpatients in the 44 participating hospitals were surveyed; 51.4 % were on at least one antibiotic at that time. Pneumonia was the most frequently reported hospital-acquired (47 %), followed by intra-abdominal sepsis (10.9 %), upper respiratory tract infections (10.6 %), and urinary tract infections (9.9 %). Ceftriaxone and piperacillin/Tazobactam were the most frequently used antibiotics (13.5 %, 9.6 %). Compliance with guidelines was reported in 70.3 % of prescriptions. Only 11.4 % of patients received a single dose of surgical prophylaxis.</p></div><div><h3>Conclusion</h3><p>Our results on antimicrobial use and hospital-acquired infection prevalence are comparable to other regional and international findings. Local guidelines are needed to reduce the excessive use of Watch and Reserve antibiotics, reduce prolonged antibiotic use after surgery, and decrease hospital-acquired infections.</p></div>","PeriodicalId":13539,"journal":{"name":"Infectious diseases now","volume":"54 4","pages":"Article 104891"},"PeriodicalIF":3.5,"publicationDate":"2024-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666991924000460/pdfft?md5=6b0cfca94b95eb83562cda3ac6887300&pid=1-s2.0-S2666991924000460-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140305513","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Environment, animals, and food as reservoirs of antibiotic-resistant bacteria for humans: One health or more?","authors":"Daniel Martak ,&nbsp;Charles P. Henriot ,&nbsp;Didier Hocquet","doi":"10.1016/j.idnow.2024.104895","DOIUrl":"10.1016/j.idnow.2024.104895","url":null,"abstract":"<div><p>Antimicrobial resistance (AMR) is a major public health challenge. For several years, AMR has been addressed through a One Health approach that links human health, animal health, and environmental quality. In this review, we discuss AMR in different reservoirs with a focus on the environment. Anthropogenic activities produce effluents (sewage, manure, and industrial wastes) that contaminate soils and aquatic environments with antibiotic-resistant bacteria (ARB), antibiotic-resistant genes (ARGs), and selective agents such as antibiotics, biocides, and heavy metals. Livestock treated with antibiotics can also contaminate food with ARB. In high-income countries (HICs), effective sanitation infrastructure and limited pharmaceutical industries result in more controlled discharges associated with human activities. Hence, studies using genome-based typing methods have revealed that, although rare inter-reservoir transmission events have been reported, human acquisition in HICs occurs primarily through person-to-person transmission. The situation is different in low- and middle-income countries (LMICs) where high population density, poorer sanitation and animal farming practices are more conducive to inter-reservoir transmissions. In addition, environmental bacteria can be a source of ARGs that, when transferred to pathogenic species under antibiotic selection pressure in environmental hotspots, produce new antibiotic-resistant strains that can potentially spread in the human community through human-to-human transmission.</p><p>The keys to reducing AMR in the environment are (<em>i</em>) better treatment of human waste by improving wastewater treatment plants (WWTPs) in HICs and improving sanitation infrastructure in LMICs, (<em>ii</em>) reducing the use of antibiotics by humans and animals, (<em>iii</em>) prioritizing the use of less environmentally harmful antibiotics, and (<em>iv</em>) better control of pharmaceutical industry waste.</p></div>","PeriodicalId":13539,"journal":{"name":"Infectious diseases now","volume":"54 4","pages":"Article 104895"},"PeriodicalIF":3.5,"publicationDate":"2024-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666991924000502/pdfft?md5=a2240314b0f7bfbbb572fcd3c679765f&pid=1-s2.0-S2666991924000502-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140318206","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Hypervirulent Klebsiella pneumoniae-related bacteremia in intensive care unit: A retrospective cohort study","authors":"Marin Moutel ,&nbsp;Edwidge Peju ,&nbsp;Martin Belan ,&nbsp;Ariane Gavaud ,&nbsp;Jean-Paul Mira ,&nbsp;Caroline Charlier ,&nbsp;Etienne Canouï ,&nbsp;Nabil Gastli","doi":"10.1016/j.idnow.2024.104892","DOIUrl":"10.1016/j.idnow.2024.104892","url":null,"abstract":"<div><h3>Introduction</h3><p>Hypervirulent <em>Klebsiella pneumoniae</em> (hvKP) bloodstream infections (BSI) have rarely been reported in critically ill patients.</p></div><div><h3>Methods</h3><p>We conducted a retrospective study of KP-BSI between January 2016 and December 2020 in an adult medical intensive care unit (ICU) of our tertiary care hospital. Hypervirulent phenotype was defined by the detection of both <em>rmpA</em> and <em>iutA</em>.</p></div><div><h3>Results</h3><p>Seventy patients diagnosed with <em>K. pneumonia</em> BSI were included, of whom 9 (13 %) had hvKP infection. Pneumonia accounted for 56 % of hvKP-BSI and for 28 % of those with cKP. Fifty-six percent of patients with hvKP-BSI were homeless, versus 2 % of those with cKP-BSI (p &lt; 0.001). The 30-day mortality rate reached 44 % for hvKP-BSI and 34 % for cKP-BSI (p = 0.7) and did not appear related to the hypervirulent phenotype in multivariable analysis.</p></div><div><h3>Discussion</h3><p>We here evidenced a new clinical entity of hvKP-BSI associated with pulmonary infection in homeless patients, which exhibits high mortality.</p></div>","PeriodicalId":13539,"journal":{"name":"Infectious diseases now","volume":"54 5","pages":"Article 104892"},"PeriodicalIF":3.5,"publicationDate":"2024-03-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666991924000472/pdfft?md5=9cf799d0fb96473699775caf56c62378&pid=1-s2.0-S2666991924000472-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140193712","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}